European Journal of Cancer
Volume 41, Issue 17 , Pages 2595-2600 , November 2005

Primary prevention of human papillomavirus-dependent neoplasia: No condom, no sex

Received 6 June 2005 ,Accepted 23 June 2005.

References 

  1. Bah E, Parkin DM, Hall AJ, et al. Cancer in the Gambia: 1988–1997. Br J Cancer. 2001;84:1207–1214
  2. Global atlas of infectious diseases: Epidemiological Fact Sheets on HIV/AIDS and sexually transmitted diseases. Available from: www.unaids.org/.
  3. Stone KM. Avoiding sexually transmitted diseases. Obstet Gynecol Clin North Am. 1990;17:789–799
  4. Oakley D, Bogue EL. Quality of condom use as reported by female clients of a family planning clinic. Am J Public Health. 1995;85:1526–1530
  5. Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity. Cancer Epidemiol Biomarkers Prev. 2001;10:101–106
  6. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Natl Cancer Inst. 1999;180:1415–1423
  7. Baldwin SB, Wallace DR, Papenfuss MR, et al. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis. 2004;31:601–607
  8. Chan SY, Ho L, Ong CK, et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol. 1992;66:2057–2066
  9. Xi LF, Carter JJ, Galloway DA, et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev. 2002;11:343–351
  10. Ahlberg DA, Jensen ER, Perez AE. Determinants of extramarital sex in the Philippines. Health Transit Rev. 1997;7(Suppl.):467–479
  11. Kusseling FS, Wenger NS, Shapiro MF. Inconsistent contraceptive use among female college students: implications for intervention. J Am Coll Health. 1995;43:191–195
  12. Singh K, Fong YF, Ratnam SS. Attitudes to AIDS and sexual behavior among a cohort of medical students in Singapore. Singapore Med J. 1992;33:58–62
  13. Detzer MJ, Wendt SJ, Solomon LJ, et al. Barriers to condom use among women attending planned parenthood clinics. Women Health. 1995;23:91–102
  14. Creatsas G. Sexually transmitted diseases and oral contraceptive use during adolescence. Ann N Y Acad Sci. 1997;816:404–410
  15. Critelli JW, Suire DM. Obstacles to condom use: the combination of other forms of birth control and short-term monogamy. J Am Coll Health. 1998;46:215–219
  16. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol. 2001;185:380–385
  17. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001;285:2995–3002
  18. Ngelangel C, Munoz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst. 1998;90:43–49
  19. Richardson H, Franco E, Pintos J, et al. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students. Sex Transm Dis. 2000;27:79–86
  20. Giuliano AR, Papenfuss M, Abrahamsen M, et al. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev. 2001;10:1129–1136
  21. Cates W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999;26(4 suppl):2–7
  22. Ross JD. Is oral contraceptive associated with genital warts?. Genitourin Med. 1996;72:330–333
  23. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Org. 2004;82:454–461
  24. Bleeker MC, Berkhof J, Hogewoning CJ, et al. HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. Br J Cancer. 2005;92:1388–1392
  25. Richardson H, Abrahamovicz M, Tellier PP, et al. Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev. 2005;14:1149–1156
  26. Shields TS, Brinton LA, Burk RD, et al. A case-control study of risk factors for invasive cervical cancer among US women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev. 2004;13:1574–1582
  27. Wald A, Koutsky L, Ashley RL, et al. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis. 1997;24:149–155
  28. Chatterjee R, Mukhopadhyay D, Murmu N, et al. Prevalence of human papillomavirus infection among prostitutes in Calcutta. J Environ Pathol Toxicol Oncol. 2001;20:113–117
  29. Janier M, Lassau F, Bloch J, et al. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris. Int J STD AIDS. 1999;10:522–526
  30. Hashido M, Lee FK, Nahmias AJ, et al. An epidemiologic study of herpes simplex virus type 1 and 2 in Japan based on type-specific serological assays. Epidemiol Infect. 1998;120:179–186
  31. Franceschi S. The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res. 2005;166:277–297
  32. Stanekova D, Ondrejka D, Habekova M, et al. Pilot study of risk behavior, voluntary HIV counselling and HIV antibody testing from saliva among inmates of prisons in Slovakia. Cent Eur J Public Health. 2001;9:87–90
  33. Shrier LA, Emans SJ, Woods ER, et al. The association of sexual risk behaviors and problem drug behaviors in high school students. J Adolesc Health. 1997;20:377–383
  34. Darney PD, Callegari LS, Swift A, et al. Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception. Am J Obstet Gynecol. 1999;180:929–937
  35. Matteelli A, Carosi G. Sexually transmitted diseases in travelers. Clin Infect Dis. 2001;32:1063–1067
  36. Gras MJ, Weide JF, Langendam MW, et al. HIV prevalence, sexual risk behavior and sexual mixing patterns among migrants in Amsterdam. AIDS. 1999;13:1953–1962
  37. Altman D. Global sex. Chicago: University of Chicago Press; 2001;
  38. O’Connor CC, Berry G, Rohrsheim R, et al. Sexual health and use of condoms among local and international sex workers in Sydney. Genitourin Med. 1996;72:47–51
  39. Messersmith LJ, Kane TT, Odebiyi AI, et al. Gender differences in sexual practices and sexually transmitted infections among adults in Lima, Peru. Am J Public Health. 1996;86:1098–1107
  40. Fenton KA, Mercer CH, McManus S, et al. Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey. Lancet. 2005;365:1246–1255
  41. Kataja V, Syrjanen S, Yliskoski M, et al. Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol. 1993;138:735–745
  42. Thomas DB, Ray RM, Koetsawang A, et al. Human papillomavirus and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am J Epidemiol. 2001;153:723–731
  43. Ferrera W, Velema JP, Figueroa M, et al. Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in Honduras. Int J Epidemiol. 2000;29:817–825
  44. Dillner J, Lenner P, Lehtinen M, et al. A population-based seroepidemiological study of cervical cancer. Cancer Res. 1994;54:134–141
  45. Castle PE, Hillier SL, Rabe LK, et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev. 2001;10:1021–1027
  46. Kjaer SK, van den Brule AJ, Bock JE, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types. Cancer Epidemiol Biomarkers Prev. 1997;6:799–805
  47. Xi LF, Koutsky LA, Galloway DA, et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst. 1997;89:796–802
  48. Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, et al. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis. 2001;28:125–130
  49. Wideroff L, Schiffman M, Haderer P, et al. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions. J Infect Dis. 1999;180:1424–1428
  50. Jakob C, Schlotter CM, Bosse U, et al. Human papillomavirus genotypes in cervical cancer with different histological features. Gynecol Obstet Invest. 2000;50:214–216
  51. Lai HC, Sun CA, Yu MH, et al. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer. 1999;84:553–557
  52. Thomas DB, Qin Q, Kuypers JM, et al. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol. 2001;153:732–739
  53. Chesson HW, Gift TL. The increasing marginal benefit of condom usage. Ann Epidemiol. 2000;10:154–159
  54. Coker AL, Sanders LC, Bond SM, et al. Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development. J Womens Health Gend Based Med. 2001;10:441–449
  55. Richardson AT, Lyong JB. The effect of condom us on squamous cell cervical intraepithelial neoplasia. Am J Obstet Gynecol. 1981;140:909–913
  56. Bleeker MC, Hogewoning CJ, Voorhorst FJ, et al. Condom use promotes regression of HPV-associated penile lesions in male sexual partners of women with CIN. Int J Cancer. 2003;107:804–810
  57. Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: population-based study in Sweden. Prev Med. 2001;32:482–491
  58. Moreno V, Xavier Bosch F, Munoz N, et al. International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 2002;359:1085–1192
  59. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364:249–256
  60. Cornish K, Lytle CD. Viral impermeability of hypoallergenic, low protein, guayule latex films. J Biomed Mater Res. 1999;47:434–437
  61. Kjaer SK, Svare EI, Worm AM, et al. Human papillomavirus infection in Danish female sex workers: decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis. 2000;27:438–445
  62. Hippelainen M, Syrjanen S, Hippelainen M, et al. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis. 1993;20:321–328
  63. Wen LM, Escourt CS, Simpson JM, et al. Risk factors for the acquisition of genital warts: are condoms protective?. Sex Transm Dis. 1999;75:312–316
  64. Parazzini F, Negri E, La Vecchia C, et al. Barrier methods of contraception and the risk of cervical neoplasia. Contraception. 1989;40:519–530
  65. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001;285:3100–3106
  66. inkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med. 1997;44:1303–1312
  67. Shanta V, Krishnamurthi S, Gajalakshmi CK, et al. Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc. 2000;98:49–52
  68. Plummer M, Franceschi S. Strategies for HPV prevention. Virus Res. 2002;89:285–293
  69. Shlay JC, McClung MW, Patnaik JL, et al. Comparison of STD prevalence by recent level of condom use among patients attending an urban STD clinic. Sex Transm Dis. 2004;31:154–160
  70. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission (Cochrane review). Cochrane Database Syst Rev. 2001;3:CD003255
  71. Rugpao S, Beyrer C, Tovanabutra S, et al. Multiple condom use and decreased condom breakage and slippage in Thailand. J Acquir Immune Defic Syndr. 1997;14:169–173
  72. Morrison CL, Ruben SM, Beeching NJ. Female sexual health problems in a drug dependencey unit. Int J STD AIDS. 1995;6:201–203
  73. Shaw M, van der Sande M, West B, et al. Prevalence of herpes simplex 2 and syphilis serology among young adults in a rural Gambian community. Sex Transm Dis. 2001;77:358–365
  74. de Visser RO, Smith AM. When always isn’t enough: implications of the late application of condoms for the validity and reliability of self-reported condom use. AIDS Care. 2000;12:221–224
  75. Biglan A, Metzler CW, Wirt R, et al. Social and behavioral factors associated with high-risk sexual behavior among adolescents. J Behav Med. 1990;13:245–261
  76. Davey-Smith G, Frankel S, Yarnell J. Sex and death: are they related? Findings from the Caerphilly Cohort Study. Br Med J. 1997;315:1641–1644
  77. Cui N, Li M, Gao E. Views of Chinese parents on the provision of contraception to unmarried youth. Reprod Health Matters. 2001;9:137–145
  78. Nzioka C. Perspectives of adolescent boys on the risks of unwanted pregnancy and sexually transmitted infections: Kenya. Reprod Health Matters. 2001;9:108–117
  79. Shepherd J, Weston R, Peersman G, et al. Interventions for encouraging sexual lifestyles and behaviors intended to prevent cervical cancer. Cochrane Database Syst Rev. 2000;(2):CD001035
  80. Roest RW, van der Meijden WI, van Dijk G, et al. Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic. Int J Epidemiol. 2001;30:580–588
  81. Goh CL, Chan RK. Prevalence of sexually transmitted diseases among commercial sex workers in Singapore from 1977 to 1993; the effects of screening measures. Ann Acad Med Singapore. 1995;24:500–504
  82. Feinleib JA, Michael RT. Reported changes in sexual behavior in response to AIDS in the United States. Prev Med. 1998;27:400–411
  83. Wight D, Raab GM, Henderson M, et al. Limits of teacher-delivered sex education: interim behavioral outcomes from randomised trial. Br Med J. 2002;324:1430–1433
  84. Weinhardt LS, Carey MP, Johnson BT, et al. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985–1997. Am J Public Health. 1999;89:1397–1405
  85. Frega A, Stentella P, De Ioris A, et al. Young women, CIN and HPV: risk factors for persistence and recurrence. Cancer Lett. 2003;196:127–134
  86. Stoner BP, Whittington WL, Aral SO, et al. Avoiding risky sex partners: perception of partners risks vs. self reported risks. Sex Transm Infect. 2003;79:197–201
  87. Heike M, Kulik JA, Harrell J, et al. Effects of UV photographs, photoaging information, and use of sunless tanning lotions on sun protection behaviors. Arch Dermatol. 2005;141:373–380
  88. Rieder J, Coupey SM. The use of nonhormonal methods of contraception in adolescents. Pediatr Clin North Am. 1999;46:671–694
  89. Tripp J, Viner R. Sexual health, contraception, and teenage pregnancy. Br Med J. 2005;330:590–593

PII: S0959-8049(05)00720-3

doi: 10.1016/j.ejca.2005.06.023

European Journal of Cancer
Volume 41, Issue 17 , Pages 2595-2600 , November 2005

Article Tools